Found "Public health policy": 1,126 results
Health Financing during COVID-19 responses in Thailand
Thailand spent 440,023 million baht on healthcare in response to the COVID-19 pandemic in 2020–2022, of which 257,892 million baht went toward COVID-19 tests, treatments, and vaccination services.
In addition to having higher hospital reserves than in the pre-pandemic period, private hospital
Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs
The Cancer Drug Fund (CDF) is a dedicated source of funding in England for increasing patient access to high-cost cancer drugs, with a fixed budget of £340 million per year, operating since 2016.
The CDF follows the appraisal by the National Institute of Health and Care Excellence (NICE) whic
Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review
This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare diseases in seven countries. The countries were purposively selected based on them having established HTA policies and availability of resources in the
Rare diseases – Talk of the Town for Some Time but What’s Next?
Because of their rarity, rare diseases are often treated with what the industry refers to as
‘orphan drugs’. These group of drugs are quite expensive because of the fewer number of people suffering from such sickness and usually provide low profit to manufacturer compared to other common drug for n
eSanjeevani, the National Telemedicine service: Bridging healthcare gaps in India
– eSanjeevani was developed primarily to tackle the challenges of inequitable healthcare access and the shortage of healthcare professionals in India
– The ‘one application’ approach ensured that only one application is used for the national telemedicine service delivery, thus ensuring interoper
Strategies for Sustainable Access: Unpacking Managed Entry Agreements (MEAs) and Innovative Medicine Access
MEAs aim at early access to high-cost innovative medicines at pre-determined terms that can ensure the financial sustainability of healthcare systems. However, their successful adoption hinges on a consideration of various factors to address the unique challenges faced by different nations.
The a
Unveiling Thailand’s Path to Open Data for Health Policy
Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading all sectors to acknowledge its significance in enhancing efficiency, fairness, and societal development.
These open data movements observed during
Cost-Effectiveness of Cascade Testing for Familial Hypercholesterolemia in Thailand: A Comparative Analysis of Genome Sequencing Methods Across Development Stages
Familial Hypercholesterolemia (FH) is a genetic disorder characterized by elevated cholesterol levels, significantly increasing the risk of heart disease. Early detection through genetic screening can play a crucial role in preventing serious health outcomes.
This study marks the first global eco
Hospitals Fear Cuts in Aid for Care to Illegal Immigrants
President Obama’s health care law is putting new strains on some of the nation’s most hard-pressed hospitals, by cutting aid they use to pay for emergency care for illegal immigrants, which they have long been required to provide.The federal government has been spending $20 billion annually to reimb
Spouses of heart attack survivors ‘suffer too’
Spouses of heart attack victims have an increased risk of depression and anxiety, even if their partner survives, Danish research suggests.The study found that in the year after losing a spouse to a heart attack, partners were three times more likely to start taking anti-depressants.Even if their pa
10 / Page